Ipamorelin is a synthetic pentapeptide growth hormone secretagogue distinguished by its endocrine selectivity. Compared to earlier secretagogues like GHRP-
Read more Ipamorelin vs. GHRP-6 and GHRP-2: Comparative Selectivity and Research Evidence
Sermorelin and ghrelin mimetics both stimulate endogenous growth hormone, but they operate through distinct molecular pathways. While Sermorelin acts via t
Read more Sermorelin vs. Ghrelin Mimetics: Comparative Receptor Pharmacology and Endocrine Pathways
CJC-1295 and Modified GRF 1-29 are synthetic growth hormone-releasing hormone analogs sharing a core peptide sequence. This comparative review explores how
Read more CJC-1295 vs. Modified GRF 1-29: Comparative Pharmacology and Receptor Kinetics
CJC-1295 is an investigational growth hormone-releasing hormone analogue engineered with Drug Affinity Complex technology for extended half-life. While ear
Read more CJC-1295 Clinical Research: Human Trials, DAC Technology, and Safety Findings
A Minto Pyramid analysis of Sermorelin (GHRH 1-29 acetate), outlining its molecular pharmacology, human clinical trial evidence, and downstream metabolic a
Read more Sermorelin (GHRH 1-29): Mechanisms, Clinical Evidence, and Research Applications